Study shows immunotherapy prior to surgery may help destroy high-risk breast cancer
A new study led by Yale Cancer Center (YCC) researchers shows women with high-risk HER2-negative breast cancer treated before surgery
Read moreA new study led by Yale Cancer Center (YCC) researchers shows women with high-risk HER2-negative breast cancer treated before surgery
Read moreImmunotherapy that involves treating cancer with the body’s own immune cells, or those of a matched donor, shows promise in
Read moreAn experimental, off-the-shelf immunotherapy that combines a targeted antibody and chemotherapy can lead to potentially durable responses in multiple myeloma
Read more